GP59 A rare cause of ‘mitochondrial disorder’: cockayne syndrome

Fisher, Arie; Asghar, Muhammad Zubair; Ryan, Stephanie; Lynch, Bryan; Green, Andrew; Knerr, Ina

doi:10.1136/archdischild-2019-epa.125

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, these criteria are neither precocious nor specific to CS [ 2 , 3 ]. In fact, most signs and symptoms in CS patients, such as cerebral atrophy, are also found in mitochondrial diseases [ 4 , 5 ]. To complicate the situation, the reported clinical and mutation spectrum of CS keeps expanding [ 2 , 6 , 7 ].…”

Section: Introductionmentioning

confidence: 99%

Identification and Characterization of a Novel Recurrent ERCC6 Variant in Patients with a Severe Form of Cockayne Syndrome B

Zayoud

Kraoua

Chikhaoui

et al. 2021

Genes

View full text Add to dashboard Cite

Cockayne syndrome (CS) is a rare disease caused by mutations in ERCC6/CSB or ERCC8/CSA. We report here the clinical, genetic, and functional analyses of three unrelated patients mutated in ERCC6/CSB with a severe phenotype. After clinical examination, two patients were investigated via next generation sequencing, targeting seventeen Nucleotide Excision Repair (NER) genes. All three patients harbored a novel, c.3156dup, homozygous mutation located in exon 18 of ERCC6/CSB that affects the C-terminal region of the protein. Sanger sequencing confirmed the mutation and the parental segregation in the three families, and Western blots showed a lack of the full-length protein. NER functional impairment was shown by reduced recovery of RNA synthesis with proficient unscheduled DNA synthesis after UV-C radiations in patient-derived fibroblasts. Despite sharing the same mutation, the clinical spectrum was heterogeneous among the three patients, and only two patients displayed clinical photosensitivity. This novel ERCC6 variant in Tunisian patients suggests a founder effect and has implications for setting-up prenatal diagnosis/genetic counselling in North Africa, where this disease is largely undiagnosed. This study reveals one of the rare cases of CS clinical heterogeneity despite the same mutation. Moreover, the occurrence of an identical homozygous mutation, which either results in clinical photosensitivity or does not, strongly suggests that this classic CS symptom relies on multiple factors.

show abstract